The scan report comes back and there’s a measurement that catches your eye. Endometrial thickness: 5.2mm. And then someone explains that this might be a problem.
For a lot of people undergoing IVF, the uterine lining is something they didn’t think much about until a monitoring scan flagged it. The focus before treatment tends to be on egg quality, embryo development, sperm parameters. The lining sits in the background until it doesn’t. And then it becomes the thing everyone is watching.
What is the lining actually doing?
The endometrium is the inner layer of the uterus. It thickens and transforms across the menstrual cycle in response to oestrogen and progesterone, preparing for a potential implantation. If pregnancy doesn’t occur, it sheds. If it does, it needs to be in a specific state, structurally and biochemically, to support an embryo attaching and developing.
In IVF, the transfer window is narrow. The embryo arrives at a precise point in the cycle, and the lining needs to be ready at that moment, not just physically thick enough but also showing the right pattern on ultrasound and expressing the right molecular signals at the tissue level.
Thickness is the measurement that’s easiest to obtain and the one most commonly reported, but it’s a proxy for a more complex state of readiness. A lining that measures 9mm and looks trilaminar on ultrasound, the classic three-layer pattern associated with good receptivity, is being read as likely ready. A thin endometrium, particularly below 7mm by most clinical thresholds, raises the question of whether that readiness is there.
Where the 7mm threshold comes from
Most IVF clinics use 7mm as a minimum endometrial thickness for proceeding with an embryo transfer. Some use 6mm. A few apply the threshold more flexibly depending on other scan characteristics.
This threshold isn’t arbitrary, but it’s also not absolute. Studies examining the relationship between endometrial thickness and IVF outcomes show that implantation and live birth rates are lower when the lining is below 7mm, and lower still below 6mm. Above 7 or 8mm, the relationship between thickness and outcome becomes less linear. A lining of 10mm and one of 14mm don’t carry meaningfully different prognoses in most cases.
The trilaminar pattern matters alongside thickness. A thin lining that shows the right layered appearance is considered more favourable than a thick but featureless lining. What’s being assessed isn’t purely how much tissue is there, but whether it looks functionally prepared.
Below around 6mm, most clinics will cancel or freeze a transfer rather than proceed. This is a protective decision. The probability of successful implantation at that thickness is low enough that proceeding risks both the cycle outcome and the loss of a potentially viable embryo.
Why linings can be thin
There are a few distinct reasons a lining may not respond adequately to oestrogen stimulation, and identifying which applies to a given patient matters for what can be done about it.
Intrauterine adhesions, scar tissue inside the uterine cavity, are one of the more common structural causes. These can form after procedures involving the uterine cavity, including dilation and curettage, hysteroscopy, myomectomy, or in some cases after infection. Asherman’s syndrome refers to significant intrauterine adhesions, but milder degrees of scarring can still affect lining development without meeting that diagnostic threshold. Hysteroscopy is typically required to assess and treat this.
Inadequate blood supply to the endometrium is another factor. The lining depends on sufficient arterial blood flow, particularly from the uterine arteries and their branches. Conditions affecting pelvic blood flow, including previous pelvic surgery, or simply anatomical variation, can result in a lining that doesn’t thicken adequately even with appropriate oestrogen levels.
Chronic endometritis, a low-grade inflammatory state in the endometrial tissue, doesn’t always cause obvious symptoms but has been associated with poor lining development and implantation failure. It’s diagnosed by endometrial biopsy, not ultrasound.
In some cases, the lining responds poorly despite what appears to be adequate oestrogen and no identifiable structural cause. This group is the most challenging to treat and the most likely to require escalating interventions.
What thin uterine lining treatment actually looks like
The standard first step is ensuring oestrogen levels are adequate. In a medicated FET cycle, oestrogen is given to stimulate lining growth. If the lining remains thin despite standard doses, the dose may be increased, the route of administration may be changed (oral, vaginal, and transdermal oestrogen have different absorption profiles), or the duration of the preparation phase may be extended.
Switching to a natural cycle protocol, where the lining develops in response to the body’s own oestrogen from a dominant follicle, is sometimes tried when medicated cycles consistently produce poor responses. Some women respond better to natural stimulation than to exogenous hormone.
Sildenafil, better known commercially by another name, has been used as an adjunct in women with persistently thin linings. Given vaginally, it acts as a vasodilator and may improve uterine blood flow. The evidence is modest and the use is off-label, but it’s offered at some centres for patients who have failed to respond to conventional preparation.
Platelet-rich plasma (PRP) intrauterine infusion has gained attention over the past several years as a treatment for thin endometrium, particularly in cases associated with Asherman’s syndrome or prior surgical damage. PRP is derived from the patient’s own blood and is infused into the uterine cavity with the intention of stimulating regeneration of the endometrial lining. The evidence is still accumulating, and it hasn’t reached the point of being standard of care, but published case series and small trials have shown thickness improvement in some patients with previously resistant thin linings.
Hysteroscopy, to identify and treat intrauterine adhesions or other cavity abnormalities, is part of the workup for most women with persistently thin linings who haven’t had recent uterine cavity assessment.
Granulocyte colony-stimulating factor (G-CSF) is another adjunct that has been studied for thin endometrium, with some reports of thickness improvement in resistant cases. Like PRP, the evidence base is limited but exists, and it may be discussed at specialist centres when other measures have not succeeded.
The natural measures question
People frequently ask about how to thicken uterine lining naturally, and it’s worth being honest about what the evidence supports.
Adequate blood flow to the uterus is relevant, and some measures that support general circulatory health may be useful in the background: avoiding smoking, staying hydrated, and light to moderate exercise before treatment cycles. None of this is a treatment for structurally thin endometrium.
Pomegranate juice and acupuncture are frequently mentioned in online fertility communities as natural approaches to improving lining. The evidence for pomegranate is negligible. The evidence for acupuncture improving endometrial thickness is limited and inconsistent. Neither should be relied on as a primary strategy.
Where natural cycle approaches help is in patients who respond better to endogenous oestrogen than to exogenous. Monitoring whether a natural FET cycle produces better lining development than a medicated one is a legitimate clinical experiment worth trying in suitable patients.
The honest position is that genuinely thin endometrium associated with structural damage or poor perfusion requires medical or procedural intervention, not lifestyle optimisation. Lifestyle measures are supportive at best in this context.
Two hypothetical profiles where this looks different
A 36-year-old preparing for a frozen embryo transfer. On oestrogen for 12 days, her lining measures 6.1mm with a partial trilaminar pattern. The clinic extends the preparation phase by five days, increases her oestrogen dose, and adds vaginal sildenafil. Rescan shows 7.4mm with clear trilaminar appearance. Transfer proceeds. In a situation like this, the thin lining was a reversible response to suboptimal stimulation rather than a structural problem, and adjusting the protocol addressed it.
A different profile: a 32-year-old with a history of two prior curettage procedures. Three FET cycle preparations have each produced a lining between 5.2 and 5.8mm despite increased oestrogen and a natural cycle attempt. Hysteroscopy reveals mild intrauterine adhesions. These are treated. A subsequent preparation cycle produces a lining of 7.9mm, and the first transfer after adhesion treatment results in pregnancy.
The second case illustrates something important. When a lining consistently fails to reach adequate thickness despite protocol adjustments, there’s usually a reason. Finding it requires looking beyond the monitoring scan.
When the lining remains resistant
Some women have persistently thin linings that don’t respond adequately despite multiple interventions. This is a genuinely difficult situation, and it’s one where clinical options thin out alongside the endometrium.
PRP and G-CSF are sometimes tried in this group. Surrogacy is, in some cases, the option that gives the best probability of a successful outcome, where a gestational carrier with a normal uterine environment carries the embryo. This is a significant step and not one that comes into the conversation lightly, but it exists as an option when the uterine environment has proved genuinely resistant to treatment.
The conversation about what to try next, and when to consider alternatives, is one a specialist needs to lead based on the specific history. There’s no universal protocol for resistant thin endometrium, and the treatment pathway is genuinely individualised.
The lining is one variable in a larger picture
Endometrial thickness is important. A thin endometrium that repeatedly prevents transfer is a meaningful problem that needs to be addressed. But it’s worth keeping in proportion. Many women with linings at the lower end of acceptable thickness have successful transfers. The 7mm threshold is a guideline, not a hard biological wall.
What matters is whether the lining, at whatever thickness, shows signs of adequate preparation: the right pattern on ultrasound, appropriate hormonal support, and ideally confirmation of the transfer timing through ERA if there’s a history of failure with otherwise good embryos.
If your lining has been flagged as borderline or thin, the first question is whether the cause is identifiable and treatable. Often it is.
Book a consultation at 9M Fertility.
→ Also read: ERA Test in IVF: How It Helps Find Your Perfect Embryo Transfer Window
→ Also read: Uterine Polyps and Fertility: Do They Need to Be Removed Before IVF?
